IHC staining of tumor sections revealed stronger cancer stemness markers (anti‐CD44, Twist, and Bmi1) and higher proliferative activity (anti‐Ki67) in tumor lesions stably expressing WT or Q311E (Fig. 5C). The gene discussed is CD44; the disease is cancer.